Guardant Health, Inc.GHNASDAQ
Loading
GH Revenue Growth (YoY Quarterly)•+39.37%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+39.37%
+0.9pp
+46.33%
-0.4pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+3.96%
+2.5pp
+3.96%
+2.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +30.16% | +20.76% | +30.95% | +38.50% | +39.37% |
| Gross Profit Growth | -47.41% | +24.76% | +43.95% | +46.69% | +46.33% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.43% | +1.77% | +1.36% | +1.43% | +3.96% |
| Weighted Average Shares Diluted Growth | +4.43% | +1.77% | +1.36% | +1.83% | +3.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +24.18% | +36.50% | +29.58% | +30.66% | +25.03% |
| Inventory Growth | +14.75% | +22.65% | +25.49% | +25.16% | +20.81% |
| Asset Growth | -16.84% | -21.14% | -17.23% | -17.02% | +35.54% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -1.31% | -3.05% | -0.52% | -0.97% | +25.93% |
| R&D Expense Growth | +4.10% | +5.63% | +5.23% | +3.04% | +5.05% |
| SG&A Expenses Growth | +34.12% | +27.03% | +38.84% | +22.88% | +30.43% |
1 / 4